Epirubicin (epirubicin): Reviews and patient testimonials

Epirubicin 2 mg/ml, solution for injection

Epirubicin Hydrochloride 2 mg/ml, solution for injection is used in the treatment of a range of neoplastic conditions including:

• Breast and gastric carcinomas,

When administered intravesically, this medicinal product has been shown to be beneficial in the treatment of:

• Papillary transitional cell carcinoma of the bladder,

• Carcinoma-in-situ,

• Prophylaxis of recurrences after transurethral resection.

Epirubicin hydrochloride 2 mg/ml solution for injection

Epirubicin is used in the treatment of a range of neoplastic conditions including:

• Carcinoma of the breast

• Advanced ovarian cancer

• Gastric cancer

• Small cell lung cancer

When administered intravesically, epirubicin has been shown to be beneficial in the treatment of:

• Papillary transitional cell carcinoma of the bladder

• Carcinoma-in-situ of the bladder

• Intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection.

Epirubicin Hydrochloride 2 mg/ml solution for injection or infusion

Epirubicin is used in the treatment of a range of neoplastic conditions including;

• Carcinoma of the breast

• Gastric cancer

When administered intravesically, epirubicin has been shown to be beneficial in the treatment of

• Papillary transitional cell carcinoma of the bladder

• Carcinoma-in-situ of the bladder.

• Prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection

Route of administration: Injectable
Molecule: epirubicin